CKS2 and Miyoshi myopathy: Prognostic relevance was assessed through Kaplan-Meier analysis of survival-associated GEO datasets (GSE24080, GSE4204), revealing significantly shorter overall survival (OS) in MM patients with high CKS2 expression (log-rank p<0.05, Figure 1D-E).